Full-automatic cryoprecipitate preparation instrument

Abstract

The invention discloses a full-automatic cryoprecipitate preparation instrument. The full-automatic cryoprecipitate preparation instrument comprises a machine body, an unfreezing box, a water tank, awater inlet pipe, a water drainage pipe, a refrigeration assembly, a freezing assembly, a temperature sensor, a touch screen, a timer, a controller and a weighing system, wherein the unfreezing box isarranged on the front surface of the machine body; the water tank is arranged at the inner bottom of the machine body; the unfreezing box is a double-layer box wall consisting of an inner box wall and an outer box wall; the unfreezing box is provided with an overflow hole, a water bath and a box cover; one end of the water inlet pipe is connected with the unfreezing box, and the other end of thewater inlet pipe is connected with the water tank; one end of the water drainage pipe is connected with the overflow hole, and the other end of the water drainage pipe is connected with the water tank; the touch screen is arranged at the top of the machine body; and the weighing system is arranged below the front surface of the unfreezing box. According to the full-automatic cryoprecipitate preparation instrument, freezing time and unfreezing time can be preset through the touch screen, frozen plasma bags in the water bath can be frozen and unfrozen, and manual operation is not needed; and moreover, the operation can be performed at night, so that the working time in the daytime is not delayed, time and labor are saved, and the working efficiency is improved.

Description

technical field [0001] The invention relates to the technical field of medical equipment, in particular to a fully automatic cryoprecipitate preparation instrument. Background technique [0002] Cryoprecipitated coagulation factor refers to the use of a specific method to melt the fresh frozen plasma within the storage period at 1 ° C to 6 ° C, separate most of the plasma, and freeze the remaining cold insoluble substances within 1 hour to become a solid state. Component blood. Cryoprecipitated clotting factor is mainly used in patients with blood diseases, such as congenital or acquired fibrinogen deficiency, congenital or acquired coagulation factor VIII deficiency, von Willebrand's disease, children and mild adult hemophilia A etc. Cryoprecipitated coagulation factor is separated from fresh frozen plasma from whole blood by the blood collection unit, and then prepared from fresh frozen plasma. At present, the preparation cycle of cryoprecipitate coagulation factors in ...

AI Technical Summary

Problems solved by technology

At present, the preparation cycle of cryoprecipitate coagulation factors in the blood bank is long. The operator needs to put the fresh plasma into the freezer to freeze, and then transfer the fresh frozen plasma frozen into a solid state to the cryoprecipitate preparation instrument for thawing to prepare the cryoprecipitate. In this process, the operator has to shuttle back and forth between different equipments, which is labor-intensive, and the fresh frozen plasma frozen into a solid state takes a long time to thaw, about 15 hours. Melting during working hours during the day will greatly reduce production efficiency and is time-consuming. force

Images